--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Gluci-Chek: diabetes and carbs" developer_entity: "Roche Diagnostics France - NPC" bundle_id: "com.roche.glucichek" app_store_id: "660671680" category: "Medical" primary_platform: "ios" primary_monetization: "Free" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2026-01-26" report_date: "2026-08-10" last_verified: "2026-08-10T00:00:00.000Z" report_version: "8.0.0_2" total_reviews: 4782 overall_rating: 2.9 sentiment: "Frustrated" sentiment_score: 25 confidence: "high" confidence_score: 0.7 top_praise_theme: "Carbohydrate tracking functionality provides essential support for users managing their daily dietary insulin requirements" top_complaint_theme: "Pay-to-access models for basic food database entries frustrate users who rely on the app for health" review_sample_size: 37 total_review_count: 37 analyzed_review_count: 37 data_age_days: 6 momentum_velocity: "maintenance" intelligence_version: 3 tags: ["medical", "free", "frustrated sentiment", "mobile app", "app review", "app analysis", "individuals", "diabetes", "using"] canonical_url: "https://marlvel.ai/apps/gluci-chek-diabetes-and-carbs" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # Gluci-Chek: diabetes and carbs Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Free - **Signal**: Rating 2.86 · Sentiment Frustrated - **Recent focus**: Pay-to-access models for basic food database entries frustrate users who rely on the app for health (top complaint) · Carbohydrate tracking functionality provides essential support for users managing their daily dietary insulin requirements (top praise) > **TL;DR:** Gluci-Chek: diabetes and carbs is a medical app by Roche Diagnostics France - NPC, rated 2.86/5 by 4.8K users, with Frustrated user sentiment (25/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** Gluci-Chek: diabetes and carbs faces Frustrated user sentiment (2.86/5 from 4.8K reviews), with users reporting pay-to-access models for basic food database entries frustrate users who rely on the app for health as the primary concern. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 2.86/5 (4.8K reviews) | | **User Mood** | Frustrated | | **Category** | Medical | | **Developer** | Roche Diagnostics France - NPC | | **Pricing** | Free | | **Platforms** | iOS & Android | | **Confidence** | High (0.7/1.0) | | **Data Age** | 6d | ## Metadata & Market Performance - **Publisher:** Roche Diagnostics France - NPC - **Category:** Medical - **Target Audience:** Individuals with diabetes using Roche Accu-Chek meters or Mallya-compatible insulin pens who require automated data logging. - **Platforms:** iOS & Android - **Version Reviewed:** 8.0.0_2 - **Report Date:** 2026-08-10 - **Signal Count:** 37 reviews analyzed - **Confidence:** High (0.7/1.0) - **App Store ID (iOS):** 660671680 - **Bundle ID:** com.roche.glucichek - **Google Play ID:** com.roche.glucichek - **Performance Trend:** Stable - **Data Window:** Analysis based on signals collected up to 2026-08-10 - **Short Description:** Manage your diabetes: meal carbohydrate calculator, blood sugar diary & insulin ## Executive Snapshot **What it is:** Gluci-Chek is a medical utility for diabetes management, providing carbohydrate tracking and blood glucose logging for users of Roche hardware on Android. **Why users hire it:** Users hire Gluci-Chek to automate the transfer of insulin and glucose data from specific medical devices, reducing the manual burden of daily diabetes monitoring. ## App DNA (Features & Intent) - **[Differentiator] Mallya Device Integration:** Automated data transfer of insulin doses from compatible pens via Bluetooth. Revenue Link: B2B partnership with Biocorp/Roche hardware ecosystem — increases switching cost and device-dependent retention. - **[Differentiator] Blood Glucose Meter Sync:** Automatic data transfer from Accu-Chek Guide or Mobile meters to the app. Revenue Link: Brand moat reinforcement — ties app usage to specific Roche hardware, increasing hardware ecosystem lock-in. * *User Intent:* Users expect seamless access across multiple devices. - **[Standard] Carbohydrate Calculator:** Database of over 700 foods with nutritional values for meal planning. Revenue Link: Retention tool that increases daily app usage by providing utility for meal tracking. * *User Intent:* Users are motivated by consistent progression and daily incentives. ## Market Position {#market-position} Gluci-Chek holds a #25 Grossing and #34 Top Free position in the French Medical category. The gap between its utility as a hardware companion and its low 2.8-star rating suggests that technical friction is currently offsetting its integration advantage. ## Monetization Strategy - **Model:** Free - **Tiers:** Free - **Analysis:** The app operates as a free utility to support the Roche hardware ecosystem, with no direct subscription or IAP monetization. ## 🔴 User Sentiment (High Confidence: 37 of 37 reviews analyzed) {#user-sentiment} - **Overall Rating:** 2.86/5 - **Platform Split:** Android 2.9/5 (4.8K ratings) - **Overall Sentiment:** Frustrated ### Top Praises - **Carbohydrate tracking functionality provides essential support for users managing their daily dietary insulin requirements** - **Data export capabilities allow users to maintain their own records of blood glucose history** ### Top Complaints (Impact Areas) - **Pay-to-access models for basic food database entries frustrate users who rely on the app for health** ## SWOT Analysis {#swot} **Core Strengths:** - Hardware-mapped Bluetooth integration creates high switching costs - Brand-backed data accuracy provides clinical trust **Growth Levers:** - Expansion into broader food database APIs could improve utility - Cross-selling digital services to existing Roche hardware users ## Recent Changes (v2 → v3) {#recent-changes} The report reflects a shift toward competitive defense, with updated market ranking data and a more focused strategy on resolving technical debt to prevent user churn to cloud-native rivals. **Overall trend**: Stable **Compared at**: 2026-08-10 ### High-impact changes - **[Added] Market Ranking Expansion** (positioning) ### Medium-impact changes - **[Added] Competitive Threat Identification** (swot) - **[Added] Digital Service Opportunity** (swot) - **[Shifted] Strategic Focus** (positioning) ## What's New - **Latest (v8.0.0_2, 6 months ago):** Optimized data update performance. ## App Momentum (Maintenance) {#momentum} - Ships generic data updates only. - No major feature release in 2026. > **Cadence:** 1 total versions · 0 majors in last 6 months · 195 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} Gluci-Chek: diabetes and carbs is a medical app that is completely free. With a 2.86/5 rating from 4.8K reviews, it faces significant user friction. > **Bottom Line:** Gluci-Chek secures its user base through hardware integration, but the lack of cloud-based data persistence creates a critical churn risk, so the team must prioritize account-based sync to defend the user funnel against cloud-native rivals. **Best for:** Individuals with diabetes using Roche Accu-Chek meters or Mallya-compatible insulin pens who require automated data logging. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Ship cloud-based account synchronization because it is the top-requested feature → unlock data-loss frustration ### Outlook: Declining Users report: The medical utility market is consolidating around cloud-native health platforms that offer seamless data portability. Gluci-Chek's reliance on local-only storage leaves it exposed to churn as users prioritize data safety over hardware-specific convenience. - 🔴 Persistent Bluetooth sync failures in the latest release disrupt the core monitoring experience, which compounds the rating drag already visible on Android. - 🔴 The lack of cloud-based account storage leads to permanent health data loss for users, accelerating churn pressure into the next quarter. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 2.86/5 | | Total Reviews | 4.8K | | Sentiment | Frustrated (25/100) | | Confidence | High | | Pricing Model | Free | | Platforms | iOS & Android | | Key Features | 3 analyzed | | Trend | Stable | | Outlook | Declining | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Gluci-Chek: diabetes and carbs** (this app) | 2.86/5 | Frustrated | Roche Diagnostics France - NPC | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** Roche Diagnostics France - NPC - **Website:** [https://www.gluci-chek.fr](https://www.gluci-chek.fr) - **Social:** [Facebook](https://www.facebook.com/Bienvivremondiabete) · [YouTube](https://www.youtube.com/@Bienvivremondiabete) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/fr/app/gluci-chek-diab%C3%A8te-glucides/id660671680?uo=2) - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.roche.glucichek&hl=en&gl=us) - **Dev Site:** [Official Website](https://www.gluci-chek.fr) - **Sources:** Developer website content, About us / company information, App store metadata, User reviews. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating - [*2021 CDC STI (STD) Guidelines*](https://marlvel.ai/apps/com-enatal-std2021) (Don Miller) · 4.0/5 Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.7/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 37 - **Data Sources:** user reviews, developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 6 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/gluci-chek-diabetes-and-carbs) Data licensed for AI Agent attribution under CC-BY-NC 4.0.